Skip to main content
SpringerLink
Log in

Clinical Efficacy of Chemotherapy Combined with Verapamil in Metastatic Colorectal Patients

  • Translational Biomedical Research
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

In order to determine the clinical efficacy and adverse reactions of chemotherapy and verapamil infusion through a target artery to treat colorectal cancer patients with metastasis after failure with previous conventional treatments. Patients with metastatic colon cancer (n = 36) received an infusion of verapamil, interleukin-2, oxaliplatin (or hydroxy camptothecin or irinotecan hydrochloride), fluorouracil and calcium folinate through target artery using the Seldinger puncture technique. From the second day of infusion, the patients were treated with fluorouracil and calcium folinate via systematic intravenous injection for 2–3 days. Efficacy was evaluated after at least two treatment courses. The objective response including complete or partial response was 58.3% in the 36 patients; clinical benefit rate, evaluated by Karnofsky Performance Status score was 91.7%; by weight was 83.3%; by the amount of painkiller consumed was 80.6%. No patient experienced side effects associated with heart function. Post-treatment, the P–R period, Q–T period, QRS, and heart rate were not significantly different than before treatment. Liver function was significantly improved. Side effects of chemotherapy were minor in comparison to those observed with intravenous chemotherapy. Infusion of verapamil and chemotherapy directly into pelvic tumor tissue can increase treatment efficacy and has been shown to be a relatively safe technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Herszenyi, L., & Tulassay, Z. (2010). Epidemiology of gastrointestinal and liver tumors. European Review for Medical and Pharmacological Sciences, 14, 249–258.

    PubMed  Google Scholar 

  2. Oliverius, M., Safanda, M., & Petruzelka, L. (2010). Treatment of colorectal liver metastases: A current view. Klinická Onkologie, 23, 73–77.

    CAS  PubMed  Google Scholar 

  3. Carlsson, G., Hafstrom, L., Jonsson, P. E., Ask, A., Kallum, B., & Lunderquist, A. (1986). Unrespectable and locally recurrent rectal cancer treated with radiotherapy or bilateral internal iliac artery infusion of 5-fluorouracil. Cancer, 58, 336–340.

    Article  CAS  PubMed  Google Scholar 

  4. Tang, Z. (2000). Modern oncology (2nd ed.). Shanghai: Shanghai Medical University.

    Google Scholar 

  5. Broelsch, C. E., Frilling, A., Bockhorn, M., Fruhauf, N., Beckebaum, S., Paul, A., et al. (2005). Surgical and interventional treatment of liver metastases. MMW Fortschritte der Medizin, 147, 21–24.

    CAS  PubMed  Google Scholar 

  6. Arnold, D., Hohler, T., Dittrich, C., Lordick, F., Seufferlein, T., Riemann, J., et al. (2008). Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: A phase Ib/II study of the AIO GI Group. Annals of Oncology, 19, 1442–1449.

    Article  CAS  PubMed  Google Scholar 

  7. Van Cutsem, E., Kohne, C. H., Hitre, E., Zaluski, J., Chang Chien, C. R., Makhson, A., et al. (2009). Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. New England Journal of Medicine, 360, 1408–1417.

    Article  PubMed  Google Scholar 

  8. Liu, Y., Li, Y., & Tang, Y. (2010). Clinical effect of verapamil combined with chemotherapeutics in perfusion treating hydrothorax and seroperitoneum. Anhui Medical and Pharmaceutical Journal, 14, 453–455.

    Google Scholar 

  9. Seldinger, S. I. (1953). Catheter replacement of the needle in percutaneous arteriography: A new technique. Acta Radiologica, 39, 368–376.

    Article  CAS  PubMed  Google Scholar 

  10. Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982). Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Research, 42, 4730–4733.

    CAS  PubMed  Google Scholar 

  11. Broxterman, H. J., Lankelma, J., & Pinedo, H. M. (1996). How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein. European Journal of Cancer, 32A, 1024–1033.

    Article  CAS  PubMed  Google Scholar 

  12. Ford, J. M., & Hait, W. N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155–199.

    CAS  PubMed  Google Scholar 

  13. Mori, T., Iwasaki, Y., Takahashi, K., & Takahashi, T. (1992). Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion. Gan To Kagaku Ryoho, 19, 1547–1549.

    CAS  PubMed  Google Scholar 

  14. Sumiyoshi, Y., Yokota, K., Akiyama, M., Kawaoto, H., & Kosugi, I. (1991). Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion. Gan To Kagaku Ryoho, 18, 1621–1626.

    CAS  PubMed  Google Scholar 

  15. Shudo, N., Mizoguchi, T., Kiyosue, T., Arita, M., Yoshimura, A., Seto, K., et al. (1990). Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Cancer Research, 50, 3055–3061.

    CAS  PubMed  Google Scholar 

  16. Ruiz Gomez, M. J., Souviron, A., Gil, L., & Martinez Morillo, M. (2001). Verapamil sensitisation to alkaloids on colchicine-selected human colon adenocarcinoma cells. Journal of Physiology and Biochemistry, 57, 343–344.

    Article  CAS  PubMed  Google Scholar 

  17. Andre, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., et al. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New England Journal of Medicine, 350, 2343–2351.

    Article  CAS  PubMed  Google Scholar 

  18. Andre, T., Colin, P., Louvet, C., Gamelin, E., Bouche, O., Achille, E., et al. (2003). Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. Journal of Clinical Oncology, 21, 2896–2903.

    Article  CAS  PubMed  Google Scholar 

  19. de Gramont, A., Bosset, J. F., Milan, C., Rougier, P., Bouche, O., Etienne, P. L., et al. (1997). Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study. Journal of Clinical Oncology, 15, 808–815.

    PubMed  Google Scholar 

  20. de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology, 18, 2938–2947.

    PubMed  Google Scholar 

  21. Wolmark, N., Bryant, J., Smith, R., Grem, J., Allegra, C., Hyams, D., et al. (1998). Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. Journal of the National Cancer Institute, 90, 1810–1816.

    Article  CAS  PubMed  Google Scholar 

  22. Russell, S. D., Saval, M. A., Robbins, J. L., Ellestad, M. H., Gottlieb, S. S., Handberg, E. M., et al. (2009). New York Heart Association functional class predicts exercise parameters in the current era. American Heart Journal, 158, S24–S30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anhui Tumor Hospital, 107 Huanhu Road, Hefei, Anhui, China

    Y. Liu, Z. Lu, P. Fan, Q. Duan, Y. Li, S. Tong & R. Lv

  2. The Provincial Hospital of Anhui, Hefei, 230031, Anhui, China

    B. Hu, L. Hu & J. Zhuang

Authors
  1. Y. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Q. Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Fan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Lu, Z., Fan, P. et al. Clinical Efficacy of Chemotherapy Combined with Verapamil in Metastatic Colorectal Patients. Cell Biochem Biophys 61, 393–398 (2011). https://doi.org/10.1007/s12013-011-9198-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9198-0

Keywords

Search

Navigation